High-Sensitivity Cardiac Troponin T Levels and Secondary Events in Outpatients With Coronary Heart Disease From the Heart and Soul Study | Cardiology | JAMA Internal Medicine | JAMA Network
[Skip to Navigation]
Access to paid content on this site is currently suspended due to excessive activity being detected from your IP address 35.170.64.36. Please contact the publisher to request reinstatement.
Original Investigation
Less Is More
May 13, 2013

High-Sensitivity Cardiac Troponin T Levels and Secondary Events in Outpatients With Coronary Heart Disease From the Heart and Soul Study

Author Affiliations

Author Affiliations: Departments of Medicine (Drs Beatty, Schiller, and Whooley) and Epidemiology and Biostatistics (Dr Whooley), University of California, San Francisco, Department of Cardiology, Kaiser Permanente San Francisco (Dr Ku), and Department of Medicine, Veterans Affairs Medical Center (Dr Whooley), San Francisco, California; and Departments of Pathology (Dr Christenson) and Medicine (Dr DeFilippi), University of Maryland School of Medicine, Baltimore.

JAMA Intern Med. 2013;173(9):763-769. doi:10.1001/jamainternmed.2013.116
Abstract

Importance Levels of high-sensitivity cardiac troponin T (hs-cTnT) predict secondary cardiovascular events in patients with stable coronary heart disease.

Objectives To determine the association of hs-cTnT levels with structural and functional measures of heart disease and the extent to which these measures explain the relationship between hs-cTnT and secondary events.

Design We measured serum concentrations of hs-cTnT and performed exercise treadmill testing with stress echocardiography in a prospective cohort study of outpatients with coronary heart disease who were enrolled from September 11, 2000, through December 20, 2002, and followed up for a median of 8.2 years.

Setting Twelve outpatient clinics in the San Francisco Bay Area.

Participants Nine hundred eighty-four patients with stable coronary heart disease.

Main Outcomes and Measures Cardiovascular events (myocardial infarction, heart failure, or cardiovascular death), determined by review of medical records and death certificates.

Results Of 984 participants, 794 (80.7%) had detectable hs-cTnT levels. At baseline, higher hs-cTnT levels were associated with greater inducible ischemia and worse left ventricular ejection fraction, left atrial function, diastolic function, left ventricular mass, and treadmill exercise capacity. During follow-up, 317 participants (32.2%) experienced a cardiovascular event. After adjustment for clinical risk factors, baseline cardiac structure and function, and other biomarkers (N-terminal portion of the prohormone of brain-type natriuretic peptide and C-reactive protein levels), each doubling in hs-cTnT level remained associated with a 37% higher rate of cardiovascular events (hazard ratio, 1.37 [95% CI, 1.14-1.65]; P = .001).

Conclusions and Relevance In outpatients with stable coronary heart disease, higher hs-cTnT levels were associated with multiple abnormalities of cardiac structure and function but remained independently predictive of secondary events. These findings suggest that hs-cTnT levels may detect an element of risk that is not captured by existing measures of cardiac disease severity.

×